Would you like to know how many people have visited this page? Or how reputable the author is? Simply
sign up for a Advocate premium membership and you'll automatically see this data on every article. Plus a lot more, too.
Become a Fan. You'll get emails whenever I post articles on OpEd News
Robert M. Davidson, M.D., Ph.D.
Kilgore, TX (USA)
OCCUPATION: practicing Internal Medicine physician
INTERESTS: public health; patient safety; medication use; medical ethics; drug safety; vaccines; health care reform; constitutional law; political affiliation: independent
DISCLAIMER: Robert Davidson, M.D. was stripped of his retained legal counsel by fiat of an Arizona trial court. He was never a pro se litigant by choice. Nothing in his postings and opinions should be considered medical or legal advice. He makes no representations or promises about the completeness, accuracy, or timeliness of any of the content in his postings and opinions. Any reliance placed on such information is therefore strictly at your own risk.
(1 comments) SHARE Sunday, November 29, 2009 Was Asthma Clinical Research Study Subject “Ghosted�
How many hospitalizations and deaths resulted from pharma-funded misinformation as to the safety of the long-acting beta agonists (“LABAsâ€), prior to FDA ordering black box warnings on the LABAs, citing increased risk of asthma-related death?
(8 comments) SHARE Friday, November 27, 2009 Are Big Pharma and the PDUFA to Blame for Healthcare Mess?
Recent $2.3 billion Pfizer settlement indicates an underlying systemic malady within the FDA. Since the passage of PDUFA, user fees have played an important role in expediting the drug approval process. The implicit underlying assumption, that expediting the drug approval process is good for public health, is seriously flawed.